Contact dermatitis - Revision history

Rossdonaldson1: /* Background */

2024-12-11T16:19:00Z

Background

← Older revision		Revision as of 16:19, 11 December 2024
Line 1:		Line 1:
	==Background==		==Background==
			{{Skin anatomy background images}}
	*Type IV [[Hypersensitivity Reaction\|hypersensitivity reaction]]		*Type IV [[Hypersensitivity Reaction\|hypersensitivity reaction]]
	*Three Types		*Three Types

2023-09-13T17:55:48Z

Clinical Features

← Older revision		Revision as of 17:55, 13 September 2023
Line 9:		Line 9:

	==Clinical Features==		==Clinical Features==
			[[File:Contact_dermatitis_around_wound.jpg\|thumbnail\|Contact dermatitis]]
			[[File:Severe contact dermatitis buprenorphine transdermal patch.jpg\|thumb\|Contact dermatitis at the application site of a transdermal patch.]]
			[[File:Severe allergic reaction to urushiol (poison oak) 4 days after exposure.jpg\|thumb\|Contact dermatitis from [[poison oak exposure]] (Day 4).]]
			[[File:Dermite de contact.jpg\|thumb\|Contact dermatitis.]]
	*[[rash\|Inflammation]] of the epidermis and dermis		*[[rash\|Inflammation]] of the epidermis and dermis
	**Erythema may take 1-3 days to show up		**Erythema may take 1-3 days to show up
Line 15:		Line 19:
	**Itchy, burning, and sometimes painful		**Itchy, burning, and sometimes painful
	**Can take weeks to heal		**Can take weeks to heal

	~~[[File:Contact_dermatitis_around_wound.jpg\|thumbnail\|Contact dermatitis]]~~
	~~[[File:Severe contact dermatitis buprenorphine transdermal patch.jpg\|thumb\|Contact dermatitis at the application site of a transdermal patch.]]~~
	~~[[File:Severe allergic reaction to urushiol (poison oak) 4 days after exposure.jpg\|thumb\|Contact dermatitis from [[poison oak exposure]] (Day 4).]]~~

	==Differential Diagnosis==		==Differential Diagnosis==

2023-09-13T17:37:29Z

Clinical Features

← Older revision		Revision as of 17:37, 13 September 2023
Line 18:		Line 18:
	[[File:Contact_dermatitis_around_wound.jpg\|thumbnail\|Contact dermatitis]]		[[File:Contact_dermatitis_around_wound.jpg\|thumbnail\|Contact dermatitis]]
	[[File:Severe contact dermatitis buprenorphine transdermal patch.jpg\|thumb\|Contact dermatitis at the application site of a transdermal patch.]]		[[File:Severe contact dermatitis buprenorphine transdermal patch.jpg\|thumb\|Contact dermatitis at the application site of a transdermal patch.]]
	[[File:Severe allergic reaction to urushiol (poison oak) 4 days after exposure.jpg\|thumb\|Contact dermatitis from poison oak exposure (Day 4).]]		[[File:Severe allergic reaction to urushiol (poison oak) 4 days after exposure.jpg\|thumb\|Contact dermatitis from [[poison oak exposure]] (Day 4).]]

	==Differential Diagnosis==		==Differential Diagnosis==

2023-09-13T17:36:28Z

Clinical Features

← Older revision		Revision as of 17:36, 13 September 2023
Line 18:		Line 18:
	[[File:Contact_dermatitis_around_wound.jpg\|thumbnail\|Contact dermatitis]]		[[File:Contact_dermatitis_around_wound.jpg\|thumbnail\|Contact dermatitis]]
	[[File:Severe contact dermatitis buprenorphine transdermal patch.jpg\|thumb\|Contact dermatitis at the application site of a transdermal patch.]]		[[File:Severe contact dermatitis buprenorphine transdermal patch.jpg\|thumb\|Contact dermatitis at the application site of a transdermal patch.]]
			[[File:Severe allergic reaction to urushiol (poison oak) 4 days after exposure.jpg\|thumb\|Contact dermatitis from poison oak exposure (Day 4).]]

	==Differential Diagnosis==		==Differential Diagnosis==

2023-09-13T17:07:51Z

Clinical Features

← Older revision		Revision as of 17:07, 13 September 2023
Line 17:		Line 17:

	[[File:Contact_dermatitis_around_wound.jpg\|thumbnail\|Contact dermatitis]]		[[File:Contact_dermatitis_around_wound.jpg\|thumbnail\|Contact dermatitis]]
			[[File:Severe contact dermatitis buprenorphine transdermal patch.jpg\|thumb\|Contact dermatitis at the application site of a transdermal patch.]]

	==Differential Diagnosis==		==Differential Diagnosis==

2023-08-18T23:29:55Z

Management

← Older revision		Revision as of 23:29, 18 August 2023
Line 30:		Line 30:
	**Barrier protection		**Barrier protection
	**Emollients		**Emollients
	**[[Topical steroids~~]] show marginal benefit.~~		*Steroids
			**Topical steroids may be used when <10% body surface area is involved
			**Oral steroids are indicated if >10% body surface area is involved

	==Disposition==		==Disposition==

2020-09-10T22:44:03Z

Background

← Older revision		Revision as of 22:44, 10 September 2020
Line 5:		Line 5:
	**Irritant contact dermatitis: solvents, neat oils, kerosene, surfactants in cosmetics, latex, drain cleaners		**Irritant contact dermatitis: solvents, neat oils, kerosene, surfactants in cosmetics, latex, drain cleaners
	**Photocontact dermatitis: interaction with UV light (lime juice and sunlight)		**Photocontact dermatitis: interaction with UV light (lime juice and sunlight)

			{{Dermatitis types}}

	==Clinical Features==		==Clinical Features==

2019-09-27T20:40:51Z

← Older revision		Revision as of 20:40, 27 September 2019
Line 2:		Line 2:
	*Type IV [[Hypersensitivity Reaction\|hypersensitivity reaction]]		*Type IV [[Hypersensitivity Reaction\|hypersensitivity reaction]]
	*Three Types		*Three Types
	**Allergic contact dermatitis: nickel, gold, chromium, poison ivy, poison oak, and poison sumac		**Allergic contact dermatitis: nickel, gold, chromium, [[poison ivy]], poison oak, and poison sumac
	**Irritant contact dermatitis: solvents, neat oils, kerosene, surfactants in cosmetics, latex, drain cleaners		**Irritant contact dermatitis: solvents, neat oils, kerosene, surfactants in cosmetics, latex, drain cleaners
	**Photocontact dermatitis: interaction with UV light (lime juice and sunlight)		**Photocontact dermatitis: interaction with UV light (lime juice and sunlight)

	==Clinical Features==		==Clinical Features==
	*Inflammation of the epidermis and dermis		*[[rash\|Inflammation]] of the epidermis and dermis
	**Erythema may take 1-3 days to show up		**Erythema may take 1-3 days to show up
	**May also have blisters and wheels		**May also have blisters and wheels
Line 28:		Line 28:
	**Barrier protection		**Barrier protection
	**Emollients		**Emollients
	**Topical steroids show marginal benefit.		**[[Topical steroids]] show marginal benefit.

	==Disposition==		==Disposition==

2016-07-23T16:51:16Z

Differential Diagnosis

@@ Line 17: / Line 17: @@
 ==Differential Diagnosis==
-===[[Generalized rashes|Generalized Rash]]===
+{{Bullous rashes DDX}}
 ==Evaluation==

2016-07-23T12:48:55Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Older revision		Revision as of 12:48, 23 July 2016
Line 47:		Line 47:
	*[[Vitiligo]]		*[[Vitiligo]]

	==~~Diagnosis~~==		==Evaluation==
	*Clinical diagnosis		*Clinical diagnosis
	*Allergist or dermatologist may use patch test to determine exact cause		*Allergist or dermatologist may use patch test to determine exact cause